128 related articles for article (PubMed ID: 30098252)
21. XPC initiation codon mutation in xeroderma pigmentosum patients with and without neurological symptoms.
Khan SG; Oh KS; Emmert S; Imoto K; Tamura D; Digiovanna JJ; Shahlavi T; Armstrong N; Baker CC; Neuburg M; Zalewski C; Brewer C; Wiggs E; Schiffmann R; Kraemer KH
DNA Repair (Amst); 2009 Jan; 8(1):114-25. PubMed ID: 18955168
[TBL] [Abstract][Full Text] [Related]
22. Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers.
Nasrallah A; Fayyad N; Kobaisi F; Badran B; Fayyad-Kazan H; Fayyad-Kazan M; Sève M; Rachidi W
Oxid Med Cell Longev; 2021; 2021():6689403. PubMed ID: 34630850
[TBL] [Abstract][Full Text] [Related]
23. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
24. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A.
Tanioka M; Budiyant A; Ueda T; Nagano T; Ichihashi M; Miyachi Y; Nishigori C
J Invest Dermatol; 2005 Aug; 125(2):244-6. PubMed ID: 16098033
[TBL] [Abstract][Full Text] [Related]
25. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
26. Xeroderma pigmentosum in a Malaysian child with identification of a novel homozygous nonsense mutation in XPC c.2167C>T.
Albela H; Ngu LH; Leong KF
Int J Dermatol; 2022 Sep; 61(9):e324-e326. PubMed ID: 35235204
[No Abstract] [Full Text] [Related]
27. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function.
Khan SG; Muniz-Medina V; Shahlavi T; Baker CC; Inui H; Ueda T; Emmert S; Schneider TD; Kraemer KH
Nucleic Acids Res; 2002 Aug; 30(16):3624-31. PubMed ID: 12177305
[TBL] [Abstract][Full Text] [Related]
28. In vivo destabilization and functional defects of the xeroderma pigmentosum C protein caused by a pathogenic missense mutation.
Yasuda G; Nishi R; Watanabe E; Mori T; Iwai S; Orioli D; Stefanini M; Hanaoka F; Sugasawa K
Mol Cell Biol; 2007 Oct; 27(19):6606-14. PubMed ID: 17682058
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and structural domain analysis of xeroderma pigmentosum complementation group C protein.
Bunick CG; Miller MR; Fuller BE; Fanning E; Chazin WJ
Biochemistry; 2006 Dec; 45(50):14965-79. PubMed ID: 17154534
[TBL] [Abstract][Full Text] [Related]
30. Xeroderma pigmentosum genes and melanoma risk.
Paszkowska-Szczur K; Scott RJ; Serrano-Fernandez P; Mirecka A; Gapska P; Górski B; Cybulski C; Maleszka R; Sulikowski M; Nagay L; Lubinski J; Dębniak T
Int J Cancer; 2013 Sep; 133(5):1094-100. PubMed ID: 23436679
[TBL] [Abstract][Full Text] [Related]
31. DNA-based diagnosis of xeroderma pigmentosum group C by Whole-genome scan using single-nucleotide polymorphism microarray.
Lam CW; Cheung KK; Luk NM; Chan SW; Lo KK; Tong SF
J Invest Dermatol; 2005 Jan; 124(1):87-91. PubMed ID: 15654957
[TBL] [Abstract][Full Text] [Related]
32. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of novel mutations in Cockayne syndrome type A and xeroderma pigmentosum group C subjects.
Ridley AJ; Colley J; Wynford-Thomas D; Jones CJ
J Hum Genet; 2005; 50(3):151-154. PubMed ID: 15744458
[TBL] [Abstract][Full Text] [Related]
34. Monozygotic twins with group C xeroderma pigmentosum due to a compound heterozygous mutation in XPC gene.
Zhang SD; Long F; Ai D; Li P; Feng S; Rajbanshi B; Zhao J
J Dermatol; 2019 Mar; 46(3):e80-e81. PubMed ID: 30101995
[No Abstract] [Full Text] [Related]
35. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
36. c.1643_1644delTG XPC mutation is more frequent in Moroccan patients with xeroderma pigmentosum.
Senhaji MA; Abidi O; Nadifi S; Benchikhi H; Khadir K; Ben Rekaya M; Eloualid A; Messaoud O; Abdelhak S; Barakat A
Arch Dermatol Res; 2013 Jan; 305(1):53-57. PubMed ID: 23143338
[TBL] [Abstract][Full Text] [Related]
37. Genotype-specific Trp53 mutational analysis in ultraviolet B radiation-induced skin cancers in Xpc and Xpc Trp53 mutant mice.
Reis AM; Cheo DL; Meira LB; Greenblatt MS; Bond JP; Nahari D; Friedberg EC
Cancer Res; 2000 Mar; 60(6):1571-9. PubMed ID: 10749125
[TBL] [Abstract][Full Text] [Related]
38. Centrin 2 stimulates nucleotide excision repair by interacting with xeroderma pigmentosum group C protein.
Nishi R; Okuda Y; Watanabe E; Mori T; Iwai S; Masutani C; Sugasawa K; Hanaoka F
Mol Cell Biol; 2005 Jul; 25(13):5664-74. PubMed ID: 15964821
[TBL] [Abstract][Full Text] [Related]
39. A novel frameshift mutation in the XPC gene in a Moroccan patient: a case report.
Doubaj Y; Smaili W; Laarabi FZ; Sefiani A
J Med Case Rep; 2017 Jun; 11(1):158. PubMed ID: 28615033
[TBL] [Abstract][Full Text] [Related]
40. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
